COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS

In this article, a retrospective analysis of the medical histories was carried out in order to develop an individualized approach to treating COVID-19. Questions were raised about the advisability of the universal immunosuppressive therapy, the need to prescribe glucocorticosteroids only taking into...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I. Kh. Borukaeva, Z. Kh. Abazova, F. Kh. Temirzhanova, M. M. Yusupova
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2021
Materias:
Acceso en línea:https://doaj.org/article/e892058965be447394eeb8862d8f44a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e892058965be447394eeb8862d8f44a4
record_format dspace
spelling oai:doaj.org-article:e892058965be447394eeb8862d8f44a42021-11-18T08:03:51ZCOVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS1563-06252313-741X10.15789/1563-0625-COO-2265https://doaj.org/article/e892058965be447394eeb8862d8f44a42021-10-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2265https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XIn this article, a retrospective analysis of the medical histories was carried out in order to develop an individualized approach to treating COVID-19. Questions were raised about the advisability of the universal immunosuppressive therapy, the need to prescribe glucocorticosteroids only taking into account the cytokine profile of patients, the relationship of glucocorticosteroid therapy and carbohydrate metabolism disorders, as one of the most common complications of pharmacotherapy COVID-19 in the patients we studied. Unjustified immunosuppression in the stage of active fight against the infectious agent as a factor of chronization of the process and decrease of the body reactivity, as well as neutralization by immunosuppressive therapy of factors of protection of innate non-specific immunity mobilized to fight the causative agent. The importance of taking into account the probability of thrombosis with consideration of coagulogram indices and thrombosis markers (D-dimer, fibrin degradation products) does not exclude the risk of the hemorrhagic complications when prescribing high doses of anticoagulants. Antibacterial therapy for uncomplicated viral infections is neither an etiologic nor a pathogenetic treatment option. In addition, it leads to the emergence of resistant strains of microorganisms as a result of mutational variability and evolutionary adaptations of bacteria, which greatly complicates the choice of an effective antibacterial drug in some cases. Antithrombotic, glucocorticosteroid and antibacterial therapy should be clinically and laboratory justified in each individual case. The article focuses on the safety of prescribing antipodagric agents in the treatment of COVID-19 as anti-inflammatory. The review considers all the above-mentioned aspects of COVID-19 therapy with reference to foreign studies, describes options for the pathophysiological development of infection. We note the need to develop systematic data on coronavirus, changes that the pathogen induces in the body. This will allow the development of innovative and effective therapeutic strategies for the treatment of the new coronavirus infection.I. Kh. BorukaevaZ. Kh. AbazovaF. Kh. TemirzhanovaM. M. YusupovaSPb RAACIarticlecoronavirus infectionpandemicinfectious disease covid-19immunitycytokine stormacute respiratory distress syndromepathogenetic therapyImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 909-914 (2021)
institution DOAJ
collection DOAJ
language RU
topic coronavirus infection
pandemic
infectious disease covid-19
immunity
cytokine storm
acute respiratory distress syndrome
pathogenetic therapy
Immunologic diseases. Allergy
RC581-607
spellingShingle coronavirus infection
pandemic
infectious disease covid-19
immunity
cytokine storm
acute respiratory distress syndrome
pathogenetic therapy
Immunologic diseases. Allergy
RC581-607
I. Kh. Borukaeva
Z. Kh. Abazova
F. Kh. Temirzhanova
M. M. Yusupova
COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS
description In this article, a retrospective analysis of the medical histories was carried out in order to develop an individualized approach to treating COVID-19. Questions were raised about the advisability of the universal immunosuppressive therapy, the need to prescribe glucocorticosteroids only taking into account the cytokine profile of patients, the relationship of glucocorticosteroid therapy and carbohydrate metabolism disorders, as one of the most common complications of pharmacotherapy COVID-19 in the patients we studied. Unjustified immunosuppression in the stage of active fight against the infectious agent as a factor of chronization of the process and decrease of the body reactivity, as well as neutralization by immunosuppressive therapy of factors of protection of innate non-specific immunity mobilized to fight the causative agent. The importance of taking into account the probability of thrombosis with consideration of coagulogram indices and thrombosis markers (D-dimer, fibrin degradation products) does not exclude the risk of the hemorrhagic complications when prescribing high doses of anticoagulants. Antibacterial therapy for uncomplicated viral infections is neither an etiologic nor a pathogenetic treatment option. In addition, it leads to the emergence of resistant strains of microorganisms as a result of mutational variability and evolutionary adaptations of bacteria, which greatly complicates the choice of an effective antibacterial drug in some cases. Antithrombotic, glucocorticosteroid and antibacterial therapy should be clinically and laboratory justified in each individual case. The article focuses on the safety of prescribing antipodagric agents in the treatment of COVID-19 as anti-inflammatory. The review considers all the above-mentioned aspects of COVID-19 therapy with reference to foreign studies, describes options for the pathophysiological development of infection. We note the need to develop systematic data on coronavirus, changes that the pathogen induces in the body. This will allow the development of innovative and effective therapeutic strategies for the treatment of the new coronavirus infection.
format article
author I. Kh. Borukaeva
Z. Kh. Abazova
F. Kh. Temirzhanova
M. M. Yusupova
author_facet I. Kh. Borukaeva
Z. Kh. Abazova
F. Kh. Temirzhanova
M. M. Yusupova
author_sort I. Kh. Borukaeva
title COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS
title_short COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS
title_full COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS
title_fullStr COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS
title_full_unstemmed COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS
title_sort covid-19: observations on standard treatment algorithms
publisher SPb RAACI
publishDate 2021
url https://doaj.org/article/e892058965be447394eeb8862d8f44a4
work_keys_str_mv AT ikhborukaeva covid19observationsonstandardtreatmentalgorithms
AT zkhabazova covid19observationsonstandardtreatmentalgorithms
AT fkhtemirzhanova covid19observationsonstandardtreatmentalgorithms
AT mmyusupova covid19observationsonstandardtreatmentalgorithms
_version_ 1718422323596361728